Activated marrow infiltrating lymphocytes
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Activated marrow infiltrating lymphocytes, covering 2019-10-08 to 2025-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation [Phase 1]